Clinically relevant vaccine-vaccine interactions: A guide for practitioners

BioDrugs

Volumn 9, Issue 6, 1998, Pages 443-453

  Gizurarson, Sveinbjörn ^a  

^a UNIVERSITY OF ICELAND   (Iceland)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; HEPATITIS B VACCINE; MEASLES VACCINE; MENINGOCOCCUS VACCINE; MUMPS VACCINE; ORAL POLIOMYELITIS VACCINE; PERTUSSIS VACCINE; PNEUMOCOCCUS VACCINE; POLIOMYELITIS VACCINE; ROTAVIRUS VACCINE; SMALLPOX VACCINE; TETANUS TOXOID; TICK BORNE ENCEPHALITIS VACCINE; TYPHUS VACCINE; VACCINE; YELLOW FEVER VACCINE;

ANTIBODY RESPONSE; ARTICLE; CHOLERA; DIPHTHERIA; DRUG ANTAGONISM; DRUG POTENTIATION; HEPATITIS B; HUMAN; IMMUNOGENICITY; INFLUENZA; MEASLES; MENINGOCOCCOSIS; NONHUMAN; PERTUSSIS; POLIOMYELITIS; PRIORITY JOURNAL; SMALLPOX; STREPTOCOCCUS INFECTION; TETANUS; TICK BORNE ENCEPHALITIS; TUBERCULOSIS; VACCINATION; YELLOW FEVER;

EID: 0031859826     PISSN: 11738804     EISSN: None     Source Type: Journal    
DOI: 10.2165/00063030-199809060-00002     Document Type: Article

References (70)

1. D'Arcy PF. Vaccine-drug interactions. DICP 1984; 18: 697-700
2. Grabenstein JD. Drug interactions involving immunological agents. Part I. Vaccine-vaccine, vaccine-immunoglobulin, and vaccine-drug interactions. DICP 1990; 24: 67-81
3. Gizurarson S. Optimal delivery of vaccines: clinical pharmacokinetic considerations. Clin Pharmacokinet 1996; 30: 1-15
4. Mitchell VS, Philipose NM, Sanford JP, et al. The children's vaccine initiative: achieving the vision. Institute of Medicine. Washington DC: National Academy Press, 1993
5. Mulholland EK, Hoestermann A, Ward JI, et al. The use of Haemophilus influenzae type b-tetanus toxoid conjugate vaccine mixed with diphtheria-tetanus-pertussis vaccine in Gambian infants. Vaccine 1996; 14: 905-9
6. Deforest A, Long SS, Lischner HW, et al. Simultaneous administration of measles-mumps-rubella vaccine with booster doses of diphtheria-tetanus-pertussis and poliovirus vaccine. Pediatrics 1988; 81: 237-46
7. Gammanco G, De Grandi V, Lupo L, et al. Interference of oral poliovirus vaccine on RIT 4237 oral rotavirus vaccine. Eur J Epidemiol 1988; 4: 121-3
8. Insel RA. Potential alteration in immunogenicity by combining or simultaneously administering vaccine components. Ann NY Acad Sci 1995; 754: 35-47
9. Buynak EB, Weibel RE, Whitman JE, et al. Combined live measles, mumps, and rubella virus vaccine. JAMA 1969; 207: 2259-62
10. Ambrosch F, Fritzell B, Gregor J, et al. Combined vaccination against yellow fever and typhoid fever: a comparative trial. Vaccine 1994; 12: 625-8
11. Melnick JL. Live attenuated poliovirus vaccines. In: Plotkin SA, Mortimer EA, editors. Vaccines. 2nd ed. Philadelphia: WB Saunders Company, 1994; 155-204
12. Corbel MJ. Control testing of combined vaccines: a consideration of potential problems and approaches. Biologicals 1994; 22: 353-60
13. McGhee JR, Mestecky J, Dertzbaugh MT, et al. The mucosal immune system: from fundamental concepts to vaccine development. Vaccine 1992; 10: 75-88
14. Saldarin RJ. Strategies for developing combination vaccines. Ann NY Acad Sci 1995; 754: 17-22
15. Galbraith NS, Crosby G, Barnes JM, et al. Simultaneous immunization with BCG, diphtheria-tetanus, and oral poliomyelitis vaccines in children aged 13-14. BMJ 1971; 2: 193-7
16. Labusquière R. Associated vaccines. Bull Int Union Tuberc 1973; 48: 53-5
17. Kaplan JE, Nelson DB, Schonberger LB, et al. The effect of immunoglobulin on the response to trivalent oral poliovirus and yellow-fever vaccinations. Bull World Health Organ 1984; 62: 585-90
18. Felsenfeld O, Wolf RH, Gyr K, et al. Simultaneous vaccination against cholera and yellow fever. Lancet 1973; I: 457-8
19. Gapochko KG, Vasilenko AZh, Misnikov OP, et al. The clinico-immunological validation of associated immunization. Voen Med Zh 1992 Mar; 3: 35-8
20. Gapochko KG, Vasilenko AZh, Stepanov AV, et al. The experimental validation of associated immunization with paired combinations of vaccines. Voen Med Zh 1991 Sep; 9: 46-9
21. Poveda JD, Raccurt CP, Le Fur R, et al. The inhibiting effect of anticholera vaccination carried out simultaneously or at short intervals on yellow fever immunization: is it real or assumed? Results of a retrospective study. Bull Soc Pathol Exot 1990; 83: 525-36
22. Gateff C, Dodin A, Wiart J. A comparison of the serological effects of classical cholera vaccine and of purified fraction vaccine, with or without simultaneous yellow fever vaccine. Ann Microbiol Paris 1975; 126: 231-46
23. Ferreccio C, Clemens J, Avendano A, et al. The clinical and immunological response of Chilean infants to Haemophilus influenzae type b polysaccharide-tetanus protein conjugate vaccine coadministered in the same syringe with diphtheria-tetanus toxoids-pertussis vaccine at two, four and six months of age. Pediatr Infect Dis J 1991; 10: 764-71
24. Redhead K, Sesardie D, Yost SE, et al. Interaction of Haemophilus influenzae type b conjugate vaccines with diphtheria-tetanus-pertussis vaccine in control tests. Vaccine 1994; 12: 1460-6
25. Watemberg N, Dagan R, Arbelli Y, et al. Safety and immunogenicity of Haemophilus type b-tetanus protein conjugate vaccine, mixed in the same syringe with diphtheria-tetanus-pertussis vaccine in young infants. Pediatr Infect Dis J 1991; 10: 758-61
26. Paradiso PR, Hogerman DA, Madore DV, et al. Safety and immunogenicity of a combined diphtheria, tetanus, pertussis and Haemophilus influenzae type b vaccine in young infants. Pediatrics 1993; 92: 1-6
27. Avendano A, Ferrecio C, Lagos R, et al. Haemophilus influenzae type b polysaccharide-tetanus protein conjugate vaccine does not depress serological response to diphtheria tetanus or pertussis antigens when co-admmisiercd in the same syringe with diphtheria-tetanus-pertussis vaccine at two, four, and six months of age. Pediatr Infect Dis J 1993; 12: 638-43
28. Clemens J, Brenner R, Rao M. Interactions between PRP-T vaccine against Haemophilus influenzae type b and conventional infant vaccines: lessons for future studies of simultaneous immunization and combined vaccines. Ann NY Acad Sci 1995; 754: 255-66
29. Lepow ML, Peter G, Glode MP, et al. Response of infants to Haemophilus influenzae type b polysaccharide and diptheria-tetanus-pertussis vaccines in combination. J Infect Dis 1984; 149: 950-5
30. Clemens JD, Ferrecio C, Levine MM, et al. Impact of Haemophilus influenzae type b polysaccharide-tetanus protein conjugate vaccine on responses to concurrently administered diphtheria tetanus pertussis vaccine. JAMA 1992; 267: 673-8
31. Eskola J, Ölander R-M, Hovi T, et al. Randomised trial of the effect of co-administration with acellular pertussis DTP vaccine on immunogenicity of Haemophilus influenzae type b conjugate vaccine. Lancet 1996; 348: 1688-92
32. Edwards KM, Decker MD. Acellular pertussis vaccines for infants. N Engl J Med 1996; 334: 391-2
33. Zepp F, Knuf M, Habermehl P, et al. Pertussis-specific cell-mediated immunity in infants after vaccination with a tricomponent acellular pertussis vaccine. Infect Immun 1996; 64: 4078-84
34. Schmitt HJ, Schuind A, Knuf M, et al. Clinical experience of a tricomponent acellular pertussis vaccine diffused with diphtheria and tetanus toxoids for primary vaccination in 22,505 infants. J Pediatr 1995; 129: 695-710
35. Greco D, Salmaso S, Mastramonio P, et al. A controlled trial of two acellular vaccines and one whole-cell vaccine against pertussis. N Engl J Med 1996; 334: 341-8
36. Paradiso PR. Combination vaccines for diphtheria, tetanus, pertussis, and Haemophilus influenzae type b. Ann NY Acad Sci 1995; 754: 108-113
37. Gold R, Scheifele D, Barreto L, et al. Safety and immunogenicity of Haemophilus influenzae vaccine (tetanus toxoid conjugate) administered concurrently or combined with diphtheria and tetanus toxoids, pertussis vaccine and inactivated poliomyelitis vaccine to healthy infants at two, four and six months of age. Pediatr Infect Dis J 1994; 13: 348-55
38. John JJ, Selvakumar R. Mixing measles vaccine with DPT and DPTP. Lancet 1985; I: 1154
39. Ruben FL, Smith EA, Foster SO, et al. Simultaenous administration of smallpox, measles, yellow fever, and diphtheria-pertussis-tetanus antigens to Nigerian children. Bull World Health Organ 1973; 48: 175-81
40. Mazert MC, Chabanier G, Adamowicz P, et al. Association of hepatitis B vaccine with other vaccines: laboratory animals study. Dev Biol Stand 1983; 54: 53-62
41. Aristegui J, Muiz J, Perez-Legorburu A, et al. Newborn universal immunisation against hepatitis B: immunogenicity and reactogenicity of simultaneous administration of diphtheria/tetanus/pertussis (DTP) and oral polio vaccines with hepatitis B vaccine at 0, 2 and 6 months of age. Vaccine 1995; 13: 973-7
42. Da-Villa G, Picciotto L, Ribera G, et al. Effective antibody response in newborn babies living in Maldives to simultaHaeneous vaccination against hepatitis B, poliomyelitis, diphtheria and tetanus. Vaccine 1995; 13: 795-8
43. Coursaget P, Yvonnet B, Relyveld EH, et al. Simultaneous administration of diphtheria/tetanus/pertussis/polio vaccine and hepatitis B vaccine in a simplified immunization programme. Dev Biol Stand 1986; 65: 169-75
44. Coursaget P, Yvonnet B, Relyveld TH, et al. Simultaneous administration of diphtheria-tetanus-pertussis-polio and hepatitis B vaccine in a simplified immunization programme: immune response to diphtheria toxoid, tetanus toxoid, pertussis, and hepatitis B surface antigen. Infect Immun 1986; 51: 784-7
45. Papaevangelou G, Karvelis E, Alexiou D, et al. Evaluation of a combined tetravalent diphtheria, tetanus, whole-cell pertussis and hepatitis B candidate vaccine administered to healthy infants according to a three-dose vaccination schedule. Vaccine 1995; 13: 175-8
46. Yvonnet B, Coursaget P, Deubel V, et al. Simultaneous administration of hepatitis B and yellow fever vaccines. Dev Biol Stand 1986; 65: 205-7
47. Wright PF, Okabe N, McKee Jr KT, et al. Cold-adapted recombinant influenza A virus vaccines in seronegative young children. J Infect Dis 1982; 146: 71-9
48. Wright PF, Bahragava M, Johnson PR, et al. Simultaneous administration of live attenuated influenza A vaccines representing different serotypes. Vaccine 1985; 3: 305-8
49. Belshe RB, Anderson EL, Newman E, et al. Immunization of infants and young children with live attenuated trivalent cold recombinant influenza A H1N1, H3N2 and B vaccine. J Infect Dis 1992; 165: 727-32
50. Honkanen PO, Keistinen T, Kivela SE. Reactions following administration of influenza vaccine alone or with pneumococcal vaccine to the elderly. Arch Intern Med 1996; 156: 205-8
51. Hilleman RM, Carlson AJ, McLean AA, et al. Streptococcus pneumoniae polysaccharide vaccine: age and dose responses, safety, persistence of antibody, revaccination, and simultaneous administration of pneumococcal and influenza vaccines. Rev Infect Dis 1981; 3 Suppl.: S31-42
52. McCue JD. Adverse reactions to simultaneous influenza and pneumococcal vaccination. J Fam Pract 1981; 13: 175-7
53. Mufson MA, Krause HE, Tarrant CJ, et al. Polyvalent pneumococcal vaccine given alone and in combination with bivalent influenza virus vaccine. Proc Soc Exp Biol Med 1980; 163: 498-503
54. Houston TP. Small-vessel vasculitits following simultaneous influenza and pneumococcal vaccination. NY State J Med 1983; 83: 1182-3
55. Bentley DW. Vaccinations. Clin Geriatr Med 1992; 8: 745-60
56. Ajjan N, Fayet MTh, Biron G, et al. combination of attenuated measles vaccine (Schwarz) with meningococcus A and A+C vaccine. Dev Biol Stand 1978; 41: 209-19
57. Karchmer AW, Friedman JP, Casey HL, et al. Simultaneous administration of live virus vaccines: measles, mumps, poliomyelitis, and smallpox. Am J Dis Child 1971; 121: 382-8
58. Fulginiti VA, editor. Immunization in clinical practice. Philadelphia: JB Lippincott, 1982: 145-50
59. Weibel RE, Stokes Jr J, Buynak EB, et al. Clinical-laboratory experiences with combined dried live measles-smallpox vaccine. Pediatrics 1966; 37: 913-20
60. Meyer Jr HM, Hostetler Jr DD, Bernheim BC, et al. Response of Volta children to jet inoculation of combined live measles, smallpox, and yellow-fever vaccines. Bull World Health Organ 1964; 30: 783-94
61. Henderson DA, Fenner F. Smallpox and vaccinia. In: Plotkin SA, Mortimer EA, editors. Vaccines 2nd ed. Philadelphia: WB Saunders Company, 1994: 13-40
62. Migasena S, Simasathien S, Samakoses R, et al. Simultaneous administration of oral rhesus-human reassortant tetravalent (RRV-TV) rotavirus vaccine and oral poliovirus vaccine (OPV) in Thai infants. Vaccine 1995; 13: 168-74
63. Ho M-S, Floyd RL, Glass RI, et al. Simultaneous administration of rhesus rotavirus vaccine and oral poliovirus vaccine: immunogenicity and reactogenicity. Pediatr Infect Dis J 1989; 8: 692-6
64. Parkman PD. Combined and simultaneously administered vaccines: a brief history. Ann NY Acad Sci 1995; 754: 1-9
65. Chen RT, Haber P, Mullen JR. Surveillance of the safety of simultaneous administration of vaccines. Ann NY Acad Sci 1995; 754: 309-20
66. Arbeter AM, Starr SE, Plotkin SA. Varicella vaccine studies in healthy children and adults. Pediatrics 1986; 78 Suppl.: 748-56
67. Gizurarson S, Aggerbeck H, Heron I. Non-ionic surfactants and mono-/diglycerides as mucosal adjuvants for intranasal vaccination of humans [abstract]. Mucosal Immunol Update 1996; 4: 33
68. Aprile MA, Warklaw AC. Aluminium compounds as adjuvants for vaccines and toxoids in man: a review. Can J Public Health 1966; 57: 343-54
69. Madore DV. Progress and challenges for a new combination vaccine composed of diphtheria, tetanus, acellular pertussis, and Haemophilus b conjugate. Ann NY Acad Sci 1995; 754: 356-8
70. Halperin SA, Eastwood BJ, Barreto L, et al. Adverse reactions and antibody response to four doses of acellular or whole cell pertussis vaccine combined with diphtheria and tetanus toxoids in the first 19 months of life. Vaccine 1996; 14: 767-72